3M syndrome (Miller, McKusick, Malvaux): Another cause of genetic short stature
PDF (Español (España))

Keywords

3M syndrome
CUL7
Growth hormone
Short stature
Genetics
Endocrinology

How to Cite

Noreña Gomez, S. I., Calero Polanco, A. M. ., González Valencia, G. M. ., Botero Hernández, J. ., Forero Torres, A. C., & Zuluaga Espinosa, N. A. . (2024). 3M syndrome (Miller, McKusick, Malvaux): Another cause of genetic short stature. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 11(3). https://doi.org/10.53853/encr.11.3.900

Abstract

Background: Linear growth during childhood is a process regulated and affected by many factors involved, such as prenatal, nutritional, hormonal, environmental or genetic. Short stature has been universally defined as a child with a score of less than 2 standard deviations for his or her age and sex. On the other hand, genetic short stature is a rare condition, which should be suspected in patients with severe short stature (defined as a height below less than 3 standard deviations according to World Health Organization curves), who present disproportions in body measurements or who have associated malformations. We describe the case of a schoolgirl with clinical findings and molecular studies that led to the diagnosis of 3M Syndrome.

Purpose: To present a rare cause of short stature of genetic origin in a pediatric patient.

Case presentation: Female patient aged 9 years and 10 months, with a perinatal history of intrauterine growth restriction and with anthropometry at birth compatible with parameters of small for gestational age. On physical examination, she presented severe short stature (-4.98 SD WHO curves), phenotype with prominent forehead, triangular face, borderline and rotated ears, bulbous nose and thick lips, with a pointed chin and narrow thorax. Her IQ and karyotype were normal. An individual whole exome sequencing was performed which reported a homozygous pathogenic variant in the CUL7 gene c.2398-2A>G, confirming the diagnosis of 3M Syndrome.

Discussion and conclusion: The etiological diagnosis of genetic short stature is challenging, and clinical and biochemical data may not be sufficient, requiring the use of new generation molecular tests that allow in some cases to find the etiology, guide the treatment and know the prognosis. In this patient, the clinical exome study allowed the diagnosis of 3M Syndrome and guided the intervention, avoiding economic expenses, prolonged treatments and false expectations about the use of growth hormone, which may not have an adequate response in this condition.

3M syndrome should be considered within the differential diagnosis of short stature, especially when the patient has normal cognitive performance. Molecular analysis of the CUL7, OBSL1 and CCDC8 genes is necessary to confirm the clinical diagnosis in suspected cases and to provide appropriate genetic counseling and treatment.

https://doi.org/10.53853/encr.11.3.900
PDF (Español (España))

References

Yadav S, Dabas A. Approach to short stature. Indian J Pediatr. 2015;82(5):462-70. https://doi.org/10.1007/s12098-014-1609-y

Perchard R, Murray PG, Clayton PE. Approach to the patient with short stature: genetic testing. J Clin Endocrinol Metab. 2023;108(4):1007-17. https://doi.org/10.1210/clinem/dgac637

Hokken-Koelega ACS, van der Steen M, Boguszewski MCS, Cianfarani S, Dahlgren J, Horikawa R, et al. International Consensus Guideline on Small for Gestational Age: etiology and management from infancy to early adulthood. Endocr Rev. 2023;44(3):539-65. https://doi.org/10.1210/endrev/bnad002

Xu N, Liu K, Yang Y, Li X, Zhong Y. Chinese patients with 3M syndrome: clinical manifestations and two novel pathogenic variants. Front Genet. 2023;14:1164936. https://doi.org/10.3389/fgene.2023.1164936

Isik E, Arican D, Atik T, Ooi JE, Darcan S, Ozen S, et al. A rare cause of syndromic short stature: 3M syndrome in three families. Am J Med Genet A. 2021;185(2):461-8. https://doi.org/10.1002/ajmg.a.61989

Clayton PE, Hanson D, Magee L, Murray PG, Saunders E, Abu?Amero SN, et al. Exploring the spectrum of 3?M syndrome, a primordial short stature disorder of disrupted ubiquitination. Clin Endocrinol. 2012;77(3):335-42. https://doi.org/10.1111/j.1365-2265.2012.04428.x

Vasques GA, Andrade NLM, Jorge AAL. Genetic causes of isolated short stature. Arch Endocrinol Metab. 2019;63(1):70-8. https://doi.org/10.20945/2359-3997000000105

Khachnaoui-Zaafrane K, Ouertani I, Zanati A, Kandara H, Maazoul F, Mrad R. 3M syndrome: a Tunisian seven-cases series. Eur J Med Genet. 2022;65(3):104448. https://doi.org/10.1016/j.ejmg.2022.104448

Huber C, Munnich A, Cormier-Daire V. The 3M syndrome. Best Pract Res Clin Endocrinol Metab. 2011;25(1):143-51. https://doi.org/10.1016/j.beem.2010.08.015

Simsek?Kiper PO, Taskiran E, Kosukcu C, Arslan UE, Cormier?Daire V, Gonc N, et al. Further expanding the mutational spectrum and investigation of genotype–phenotype correlation in 3M syndrome. Am J Med Genet A. 2019;179(7):1157-72. https://doi.org/10.1002/ajmg.a.61154

Karacan Küçükali G, Keskin M, Aycan Z, Sava?-Erdeve ?, Çetinkaya S. 3M syndrome: evaluating the clinical and laboratory features and the response of the growth hormone treatment: single center experience. Eur J Med Genet. 2023;66(10):104828. https://doi.org/10.1016/j.ejmg.2023.104828

Aldhoon-Hainerova I, Baranowski E, Kinning E, Dias RP. Gonadal failure in a male with 3-M Syndrome. JCEM Case Rep. 2024;2(6):luae084. https://doi.org/10.1210/jcemcr/luae084

Murray PG, Hanson D, Coulson T, Stevens A, Whatmore A, Poole RL, et al. 3-M syndrome: a growth disorder associated with IGF2 silencing. Endocr Connect. 2013;2(4):225-35. https://doi.org/10.1530%2FEC-13-0065

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2024 Revista Colombiana de Endocrinología, Diabetes & Metabolismo

Dimensions


PlumX


Downloads

Download data is not yet available.